Schonfeld Strategic Advisors LLC Buys 1,551,457 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Schonfeld Strategic Advisors LLC increased its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 1,568.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,650,377 shares of the pharmacy operator's stock after buying an additional 1,551,457 shares during the quarter. Schonfeld Strategic Advisors LLC owned about 0.19% of Walgreens Boots Alliance worth $15,398,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in WBA. First Financial Corp IN lifted its position in Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock valued at $25,000 after acquiring an additional 885 shares in the last quarter. Golden State Wealth Management LLC bought a new stake in Walgreens Boots Alliance during the fourth quarter worth $26,000. Riverview Trust Co raised its stake in shares of Walgreens Boots Alliance by 123.8% during the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock worth $27,000 after purchasing an additional 1,590 shares during the period. Venturi Wealth Management LLC purchased a new position in Walgreens Boots Alliance in the fourth quarter valued at about $28,000. Finally, Independence Bank of Kentucky bought a new position in Walgreens Boots Alliance during the fourth quarter valued at $39,000. Institutional investors own 58.59% of the company's stock.

Walgreens Boots Alliance Trading Up 0.5 %

Shares of WBA stock traded up $0.05 during trading hours on Friday, reaching $10.98. The company's stock had a trading volume of 7,844,424 shares, compared to its average volume of 21,044,179. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $18.83. The stock has a market capitalization of $9.49 billion, a P/E ratio of -1.07, a P/E/G ratio of 1.31 and a beta of 0.67. The firm's fifty day simple moving average is $10.97 and its 200 day simple moving average is $10.26.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its quarterly earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.53 by $0.10. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business had revenue of $38.59 billion for the quarter, compared to analysts' expectations of $37.90 billion. During the same quarter in the previous year, the business posted $1.20 earnings per share. The firm's revenue for the quarter was up 4.1% compared to the same quarter last year. Equities research analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. Wolfe Research raised Walgreens Boots Alliance to a "hold" rating in a report on Monday, February 24th. Royal Bank of Canada boosted their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a "sector perform" rating in a research report on Wednesday, January 15th. Truist Financial lowered their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a report on Friday, January 31st. StockNews.com began coverage on shares of Walgreens Boots Alliance in a research report on Sunday, April 27th. They issued a "hold" rating on the stock. Finally, Bank of America lifted their target price on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a research report on Monday, January 13th. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Hold" and an average target price of $10.59.

Insider Buying and Selling

In other news, Chairman Stefano Pessina acquired 832,258 shares of the firm's stock in a transaction on Sunday, April 27th. The stock was acquired at an average price of $11.01 per share, for a total transaction of $9,163,160.58. Following the completion of the acquisition, the chairman now owns 145,621,079 shares in the company, valued at $1,603,288,079.79. This trade represents a 0.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 17.50% of the stock is owned by insiders.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.